BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17925917)

  • 1. MTHFR polymorphisms as prognostic factors in sporadic colorectal cancer.
    Osian G; Procopciuc L; Vlad L
    J Gastrointestin Liver Dis; 2007 Sep; 16(3):251-6. PubMed ID: 17925917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C677T and A1298C mutations in the MTHFR gene and survival in colorectal cancer.
    Osian G; Procopciuc L; Vlad L; Iancu C; Mocan T; Mocan L
    J Gastrointestin Liver Dis; 2009 Dec; 18(4):455-60. PubMed ID: 20076818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case-control study on the polymorphisms of methylenetetrahydrofolate reductases, drinking interaction and susceptibility in colorectal cancer].
    Jiang QT; Chen K; Ma XY; Miao XP; Yao KY; Yu WP; Li LY; Zhu YM; Zhou HG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jul; 25(7):612-6. PubMed ID: 15308044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between C677T and A1298C mutations of the MTHFR gene and therapeutic prognostic elements in colorectal cancer].
    Osian G; Procopciuc L; Vlad L; Mocan T; Cristea PG
    Chirurgia (Bucur); 2010; 105(3):373-8. PubMed ID: 20726304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylenetetrahydrofolate reductase and methionine synthase polymorphisms and risk of bladder cancer in a Tunisian population.
    Ouerhani S; Oliveira E; Marrakchi R; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; Amorim A; El Gaaied AB; Prata MJ
    Cancer Genet Cytogenet; 2007 Jul; 176(1):48-53. PubMed ID: 17574963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of methylenetetrahydrofolate reductase gene polymorphisms and sex-specific survival in patients with metastatic colon cancer.
    Zhang W; Press OA; Haiman CA; Yang DY; Gordon MA; Fazzone W; El-Khoueiry A; Iqbal S; Sherrod AE; Lurje G; Lenz HJ
    J Clin Oncol; 2007 Aug; 25(24):3726-31. PubMed ID: 17704422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MTHFR C677T has differential influence on risk of MSI and MSS colorectal cancer.
    Hubner RA; Lubbe S; Chandler I; Houlston RS
    Hum Mol Genet; 2007 May; 16(9):1072-7. PubMed ID: 17350979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsynonymous polymorphisms in genes in the one-carbon metabolism pathway and associations with colorectal cancer.
    Koushik A; Kraft P; Fuchs CS; Hankinson SE; Willett WC; Giovannucci EL; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2408-17. PubMed ID: 17164363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylenetetrahydrofolate reductase C677T polymorphism in patients with gastric and colorectal cancer.
    Zeybek U; Yaylim I; Yilmaz H; Ağaçhan B; Ergen A; Arikan S; Bayrak S; Isbir T
    Cell Biochem Funct; 2007; 25(4):419-22. PubMed ID: 16927418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA repair genetic polymorphisms and risk of colorectal cancer in the Czech Republic.
    Pardini B; Naccarati A; Novotny J; Smerhovsky Z; Vodickova L; Polakova V; Hanova M; Slyskova J; Tulupova E; Kumar R; Bortlik M; Barale R; Hemminki K; Vodicka P
    Mutat Res; 2008 Feb; 638(1-2):146-53. PubMed ID: 17991492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between methylenetetrahydrofolate reductase polymorphisms, alcohol intake and oropharyngolaryngeal carcinoma in northern Italy.
    Capaccio P; Ottaviani F; Cuccarini V; Cenzuales S; Cesana BM; Pignataro L
    J Laryngol Otol; 2005 May; 119(5):371-6. PubMed ID: 15949101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interactions between the MTHFR C677T and MTHFR A1298C mutations in ischaemic stroke].
    Szolnoki Z; Somogyvári F; Szabó M; Kondacs A; Fodor L; Melegh B
    Ideggyogy Sz; 2006 Mar; 59(3-4):107-12. PubMed ID: 16634455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms of CYP2E1 and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study.
    Morita M; Le Marchand L; Kono S; Yin G; Toyomura K; Nagano J; Mizoue T; Mibu R; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Maekawa T; Yasunami Y; Takenaka K; Ichimiya H; Imaizumi N
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):235-41. PubMed ID: 19124503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the MTHFR C677T and A1298C polymorphisms on survival in patients with advanced CKD and ESRD: a prospective study.
    Jamison RL; Shih MC; Humphries DE; Guarino PD; Kaufman JS; Goldfarb DS; Warren SR; Gaziano JM; Lavori P;
    Am J Kidney Dis; 2009 May; 53(5):779-89. PubMed ID: 19272686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms as risk factors for hepatocellular carcinoma in a Korean population.
    Kwak SY; Kim UK; Cho HJ; Lee HK; Kim HJ; Kim NK; Hwang SG
    Anticancer Res; 2008; 28(5A):2807-11. PubMed ID: 19035314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the 5,10-methylenetetrahydrofolate reductase (MTHFR C677T and A1298C) polymorphisms in Korean patients with adult acute lymphoblastic leukemia.
    Oh D; Kim NK; Jang MJ; Kim HC; Lee JH; Lee JA; Ahn MJ; Kim CS; Kim HS; Park S; Chio HS; Min YH;
    Anticancer Res; 2007; 27(5A):3419-24. PubMed ID: 17970089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of cancer-related gene polymorphisms on clinicopathological features in colorectal cancer.
    Yoshiya G; Takahata T; Hanada N; Suzuki K; Ishiguro A; Saito M; Sasaki M; Fukuda S
    J Gastroenterol Hepatol; 2008 Jun; 23(6):948-53. PubMed ID: 18205772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interactive effect of methyl-group diet and polymorphism of methylenetetrahydrofolate reductase on the risk of colorectal cancer.
    Kim DH
    Mutat Res; 2007 Sep; 622(1-2):14-8. PubMed ID: 17602711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylenetetrahydrofolate reductase genotype association with the risk of follicular lymphoma.
    Ismail SI; Ababneh NA; Khader Y; Abu-Khader AA; Awidi A
    Cancer Genet Cytogenet; 2009 Dec; 195(2):120-4. PubMed ID: 19963111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methionine-dependence phenotype in the de novo pathway in BRCA1 and BRCA2 mutation carriers with and without breast cancer.
    Beetstra S; Suthers G; Dhillon V; Salisbury C; Turner J; Altree M; McKinnon R; Fenech M
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2565-71. PubMed ID: 18842997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.